SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sangamo Therapeutics, Inc. SGMO
SGMO 0.574-4.3%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: bob zagorin6/11/2008 9:46:04 AM
   of 368
 
Sangamo BioSciences-SGMO: Advise buying shares at current levels@LEER
The firm anticipates over the next year, the company's financial flexibility and value will increase from further protein manufacturing, agricultural, therapeutic and industrial programs which will emerge from SGMO's zinc finger DNA-binding protein transcription factors (ZFP-TF). Reiterate Outperform rating. :theflyo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext